Clinical Pharmacology · Nausea, Bowel, and Motility Medications
Laxatives
On this page 6 sections
In 30 seconds
Laxatives relieve constipation by different mechanisms: bulking, drawing water into the gut, stimulating motility, softening stool, lubricating passage, or acting on specific receptors. The right choice depends on the cause, the patient's kidney function and fluid status, and whether the constipation is opioid-induced. Every class carries tradeoffs — bulk-forming agents can obstruct if taken without enough fluid, osmotics can shift electrolytes, and stimulants cause cramping. Persistent, unexplained constipation with red-flag features needs evaluation, not just another laxative.
The college version
Bulk-Forming Agents
Psyllium, methylcellulose, and polycarbophil are fibers that absorb water in the gut lumen, forming a larger, softer stool that stimulates peristalsis mechanically. They mimic dietary fiber and are first-line for mild, chronic constipation, especially with irritable bowel syndrome. They require adequate fluid; taken dry or with too little water, they can swell in the esophagus or gut and cause obstruction, so patients with strictures, prior bowel surgery, or swallowing difficulty need caution.
Osmotic Agents
These pull water into the colon by osmotic gradient, softening stool and increasing volume. Polyethylene glycol (PEG) is generally preferred as a first-line osmotic because it is not appreciably absorbed or fermented and causes minimal gas or electrolyte disturbance. Lactulose, a nonabsorbable disaccharide, has a dual role: it treats constipation and, separately, lowers ammonia in hepatic encephalopathy by acidifying colonic contents and trapping ammonia as ammonium for excretion. Magnesium-containing salts (magnesium hydroxide, magnesium citrate) are effective but risk clinically significant magnesium accumulation in patients with renal impairment, where excretion is reduced. Sorbitol works similarly to lactulose osmotically and is a common ingredient in combination products.
Stimulant Laxatives
Senna and bisacodyl act directly on the enteric nervous system, increasing intestinal motility and colonic fluid and electrolyte secretion. They work faster than bulk or osmotic agents and are useful for acute relief or as part of bowel-prep regimens, but they commonly cause cramping. The older belief that intermittent stimulant use inevitably causes colonic damage or dependence is not well supported by current evidence; scheduled use in patients on opioids is standard practice, though overuse without addressing an underlying cause is discouraged.
Stool Softeners and Lubricants
Docusate is a surfactant that allows water and fat to penetrate stool, softening it. Evidence supporting its efficacy is weak, and it is generally considered less effective than osmotic or bulk agents. Mineral oil coats stool to ease passage but carries a real risk of lipoid aspiration pneumonia, particularly in patients with dysphagia, reflux, or who are bedbound, so it is avoided in those populations.
Secretagogues and Peripheral Opioid Antagonists
Lubiprostone, linaclotide, and plecanatide increase intestinal chloride and fluid secretion through distinct receptor mechanisms, used for chronic idiopathic constipation and constipation-predominant irritable bowel syndrome when other measures fail. Methylnaltrexone, naloxegol, and naldemedine are peripherally acting mu-opioid receptor antagonists (PAMORAs) built specifically for opioid-induced constipation; because they are structured to avoid crossing the blood-brain barrier, they block opioid effects on gut receptors without reversing central analgesia or precipitating withdrawal.
Clinical Framework
Before reaching for any laxative, identify and treat the underlying cause when possible — dehydration, immobility, low fiber intake, hypothyroidism, hypercalcemia, or a medication effect. Because constipation from opioids does not develop tolerance the way sedation or nausea does, a scheduled bowel regimen (not "as needed") should be started whenever an opioid is prescribed and continued for as long as the opioid is used. Bowel preparation for colonoscopy uses high-volume or low-volume osmotic regimens to fully cleanse the colon for visualization, distinct from routine constipation treatment. Red flags — blood in stool, unintentional weight loss, new constipation in an older adult, severe abdominal pain, or signs of obstruction — warrant diagnostic evaluation rather than empiric laxative therapy. Across all classes, watch for dehydration and electrolyte disturbance, especially with osmotic and stimulant agents used repeatedly or in vulnerable patients.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of your gut like a playground slide. If nothing moves, kids get stuck partway down — that's constipation. Bulk-forming laxatives add a fluffy cushion that pushes things along, but you must pour water on it or it turns into a dry lump that jams the slide. Osmotic laxatives spray water down the slide so everything glides. Stimulant laxatives give the slide a shake to move things faster, which can feel like a cramp. Stool softeners add a bit of oil so things aren't so hard. The special opioid-blocker medicines unlock just the gate at the bottom — the pain-relief part of the medicine upstairs keeps working fine.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient with chronic kidney disease wants to use a magnesium-based laxative regularly. What concern should be addressed before recommending this?
Show answer
The kidneys normally clear absorbed magnesium, so in renal impairment, magnesium can accumulate to dangerous levels with regular use, and a safer laxative class such as polyethylene glycol should be considered instead.
A nurse is starting a patient on a new opioid prescription for chronic pain. What bowel-related order should accompany this prescription, and why is it needed from the start rather than "as needed"?
Show answer
A scheduled (not as-needed) bowel regimen should be started, because opioid-induced constipation does not fade with tolerance the way other opioid side effects do, so without preventive treatment it will persist and often worsen for as long as the opioid is taken.
Quick check
3 questions here. Answers stay hidden until you check.
Which osmotic laxative is specifically useful for lowering ammonia levels in hepatic encephalopathy, in addition to treating constipation?
Why don't peripherally acting mu-opioid receptor antagonists (PAMORAs) reverse a patient's pain control?
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

